Contineum Therapeutics (CTNM) Assets: 2023-2025
Historic Assets for Contineum Therapeutics (CTNM) over the last 2 years, with Sep 2025 value amounting to $190.8 million.
- Contineum Therapeutics' Assets fell 11.66% to $190.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $190.8 million, marking a year-over-year decrease of 11.66%. This contributed to the annual value of $212.8 million for FY2024, which is 63.24% up from last year.
- Latest data reveals that Contineum Therapeutics reported Assets of $190.8 million as of Q3 2025, which was up 4.35% from $182.9 million recorded in Q2 2025.
- In the past 5 years, Contineum Therapeutics' Assets registered a high of $221.4 million during Q2 2024, and its lowest value of $123.6 million during Q1 2024.
- Its 3-year average for Assets is $184.5 million, with a median of $194.6 million in 2025.
- In the last 5 years, Contineum Therapeutics' Assets skyrocketed by 63.24% in 2024 and then declined by 17.38% in 2025.
- Over the past 3 years, Contineum Therapeutics' Assets (Quarterly) stood at $130.4 million in 2023, then spiked by 63.24% to $212.8 million in 2024, then declined by 11.66% to $190.8 million in 2025.
- Its last three reported values are $190.8 million in Q3 2025, $182.9 million for Q2 2025, and $198.3 million during Q1 2025.